Narrative review on genetic counseling for hereditary cancers: General considerations

Author:

Ulhaq Ehsan1,Huda Febin2,Suhail C.23,Sheth Harsh4,Anu R. I.25

Affiliation:

1. Department of Reproductive Genetics, Medgenome Labs Ltd, Bengaluru, Karnataka, India

2. Department of Cancer Biology and Therapeutics: Precision Oncology and Multi-Omics Clinic, Genetic Counseling Clinic, MVR Cancer Center and Research Institute, Calicut, Kerala, India

3. Department of Genomics, Yoda Lifeline Diagnostics, Hyderabad, Telangana, India

4. FRIGE’s Institute of Human Genetics, FRIGE House, Ahmedabad, Gujarat, India

5. Department of Cancer Biology and Therapeutics: Precision Oncology and Multi-Omics Clinic, Genetic Counseling Clinic, Department of Clinical Biochemistry, MVR Cancer Center and Research Institute, Calicut, Kerala, India

Abstract

ABSTRACT The field of oncology has made great strides in the last decade. There have been tremendous advancements in precision oncology and cutting-edge diagnostics to match the unprecedented rise in the incidence of cancer globally. Hereditary cancer syndromes which account for between 5-10% of the total cancer burden, occupy a novel niche, offering the opportunity to receive an early diagnosis through targeted surveillance, adopt preventive screening measures, and preemptively control the disease. To prepare this review, we searched in PubMed, international government web pages, and the National Comprehensive Cancer Network guidelines for published literature on genetic testing in hereditary cancers. This review article represents a consensus between the authors, based on the literature review, with a view to being relevant in the Indian setting. Genetic counseling plays a pivotal role in the diagnosis and management of hereditary cancers. India must adopt a streamlined approach to the treatment of hereditary cancers by enhancing awareness and incorporating the right protocols for genetic counseling. This educational series, focused on genetic counseling for hereditary and sporadic cancers, is the first step in generating awareness among individuals and clinicians in India.

Publisher

Medknow

Subject

Cancer Research,Oncology (nursing),Drug Guides,Oncology

Reference31 articles.

1. Global Cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Cancer J Clin,2021

2. Mutation prevalence tables for hereditary cancer derived from multigene panel testing;Hart,2020

3. A review of inherited cancer susceptibility syndromes;Brown;JAAPA,2020

4. The global state of the genetic counseling profession;Abacan;Eur J Hum Genet,2019

5. Cancer genetic counseling—current practice and future challenges;Schienda;Cold Spring Harb Perspect Med,2020

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Authors’ reply to Gupta et al., and Shah et al.;Cancer Research, Statistics, and Treatment;2023

2. Genetic counselling in India: The state of affairs;Cancer Research, Statistics, and Treatment;2023

3. Genetic counseling for hereditary cancers: Not everybody’s cup of tea!;Cancer Research, Statistics, and Treatment;2023

4. From diagnosis to treatment to death to bereavement to birth;Cancer Research, Statistics, and Treatment;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3